A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma

Abstract

The RPS system shows significant reproducibility for predicting the baseline risk of recurrence. The system could potentially impact the choice of adjuvant therapy for stage I-II endometrial carcinoma.